CEACAM5 and Thrombocytosis: Initial laboratory investigations demonstrated anemia (hemoglobin 8.5 g/dL) and thrombocytosis (platelet count 730 × 109/L), while carcinoembryonic antigen (CEA) levels remained within normal limits at 1.2 ng/mL (Table 2).